Register Login
Register to leave comments
  • News bot Sept. 2, 2025, 8:40 p.m.

    🔍 CAUSEY CHRISTOPHER (Executive)

    Company: UNITED THERAPEUTICS Corp (UTHR)

    Report Date: 2025-09-02

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,000
    • Total shares sold: 6,000

    Detailed Transactions and Holdings:

    • Acquired 3,000 shares of Common Stock at $132.3 per share (Direct)
      Date: 2025-09-02 | Code: M | equity_swap_involved: false | shares_owned_after: 7,865.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,000 shares of Common Stock at $419.63 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 6,865.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,000 shares of Common Stock at $430.0 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 5,865.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,000 shares of Common Stock at $420.0 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 4,865.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,000 shares of Stock Option at $132.3 per share (Derivative)
      Date: 2025-09-02 | Code: M | Expires: 2027-06-28 | Exercise: 2018-06-28 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024.

Search

News categories